Innovative Medicine — Percent Change (as a percent)

Business Segments · Percent Change (as a percent)

Johnson & Johnson Innovative Medicine — Percent Change (as a percent) decreased by 11.2% to $0.21 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $0.19 to $0.21. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ3 2025

How to read this metric

Positive growth indicates expanding market share or successful product launches; negative growth suggests market saturation or competitive pressure.

Detailed definition

Calculates the period-over-period growth rate of the Innovative Medicine segment's sales. This metric normalizes perform...

Peer comparison

Standard 'Revenue Growth Rate' reported by all public companies for their business segments.

Metric ID: jnj_segment_innovative_medicine_percent_change_as_a_percent

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$0.02$0.02$0.02$0.02-$0.34-$0.48$0.16$0.19-$0.09$0.22$0.24$0.21
QoQ Change+0.0%+0.0%+0.0%<-999%-43.7%+132.5%+19.1%-149.2%+342.4%+7.6%-11.2%
YoY Change<-999%+155.7%+146.2%+52.9%+13.9%
Range-$0.48$0.24
CAGR+118.7%
Avg YoY Growth-217.8%
Median YoY Growth+52.9%

Frequently Asked Questions

What is Johnson & Johnson's innovative medicine — percent change (as a percent)?
Johnson & Johnson (JNJ) reported innovative medicine — percent change (as a percent) of $0.21 in Q3 2025.
How has Johnson & Johnson's innovative medicine — percent change (as a percent) changed year-over-year?
Johnson & Johnson's innovative medicine — percent change (as a percent) increased by 13.9% year-over-year, from $0.19 to $0.21.
What does innovative medicine — percent change (as a percent) mean?
The percentage growth or decline in Innovative Medicine sales compared to the previous period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.